| CASE REPORT |
|
| Year : 2022 | Volume
: 9
| Issue : 4 | Page : 279-281 |
|
|
Complexities of Covishield Vaccine on COVID-Positive History Family in India after the Second (Booster) Dose
Parikshit Gautam Jamdade1, Shrinivas Gautamrao Jamdade2
1 Department of Electrical Engineering, PVGs College of Engineering and Technology, Pune, Maharashtra, India
2 Department of Physics, Nowrosjee Wadia College, Pune, Maharashtra, India
Correspondence Address:
Parikshit Gautam Jamdade
PVGs College of Engineering and Technology, Pune, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/cjhr.cjhr_50_22
|
|
|
COVID-19 epidemic severely affects the social life of people living in India. The best solution to the COVID-19 problem is the vaccination of the people. In India, COVID-19 vaccination started from January 16, 2021, mainly with the Covishield vaccine. In this study, the COVID-positive history family was selected who had taken the first and second (booster) doses residing at Pune, Maharashtra, India, was followed up to check for any side effects postvaccination. Their data were collected with participant-administered questions. The predominant side effects reported were uneasiness, pyrexia (fever), voice difference, vomiting, and headache. The side effects were started at 2–16 h postvaccination while it takes an average duration of 48–60 h to last. Analysis shows nonpresence of major and serious side effects makes the Covidshield vaccine safe for use in the COVID-positive history population.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
